In this study, the ability of NKTR-214 to preferentially bind to IL-2Rβ over IL-2Rα induces a greater CD8+ T cell to Treg cell ratio, greater exposure to IL-2 in the tumor and a more robust anti-tumor immunity in comparison to aldesleukin. The gene discussed is NKTR; the disease is neoplasm.